RE: Screen 4 - New contract2 Mar 2021 10:59
I think we need to look at market segmentation here now also. In essence ODX now have a distribution partner for a completely different market segment (ELISA antibody, likely quantitative test compared to LFT qualitative) and can expect the partner to focus on marketing activities for this whilst they focus on the LFTs.